icatibant and Hypovolemia

icatibant has been researched along with Hypovolemia* in 3 studies

3 other study(ies) available for icatibant and Hypovolemia

Article	Year
Icatibant, another piece of the therapeutic puzzle regarding hemodynamic side effects of angiotensin-converting enzyme inhibitors. Critical care (London, England), 2019, 08-28, Volume: 23, Issue:1 Topics: Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Enzyme Inhibitors; Hemodynamics; Humans; Hypovolemia	2019
Icatibant as an early rescue therapy in hypovolemic shock with converting enzyme inhibitor treatment. Critical care (London, England), 2017, 11-02, Volume: 21, Issue:1 Topics: Animals; Arterial Pressure; Bradykinin; Bradykinin B2 Receptor Antagonists; Humans; Hypovolemia; Mice	2017
One hypovolaemic shock…two kinin pathway abnormalities. Intensive care medicine, 2011, Volume: 37, Issue:7 Topics: Adult; Angioedemas, Hereditary; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Diagnosis, Differential; Female; Humans; Hypovolemia; Kinins; Shock; Tomography, X-Ray Computed	2011